Free. Unsubscribe any time.
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. filed 28 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 50 transactions and 435,853 shares. None carries the SEC's AFF10B5ONE flag; all 28 name a plan in a footnote. 9 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-03, came on the same day as the one before it (2026-09-03) and reports 1 transaction against 4 in the filing before it.
- The sales it reports total 658 shares, 29,342 fewer than the 30,000 in the filing before it.
- Its 28 plan statements rank 214th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 28 filings on file run from 2025-03-04 to 2026-09-03, and state 7 plan adoption dates, from 2024-11-22 to 2026-03-18.
Trades in Mirum Pharmaceuticals, Inc. 50
- Peetz Christopher — 2025-03-03 · S · 19,392 shares
- Peetz Christopher — 2025-03-03 · S · 20,608 shares
- Howe Jolanda — 2025-03-17 · S · 2,900 shares
- Howe Jolanda — 2025-03-17 · S · 50,111 shares
- Howe Jolanda — 2025-03-17 · S · 2,789 shares
- Howe Jolanda — 2025-03-17 · S · 1,806 shares
- Howe Jolanda — 2025-03-18 · S · 2,415 shares
- Howe Jolanda — 2025-07-02 · S · 564 shares
- Howe Jolanda — 2025-07-03 · S · 477 shares
- Howe Jolanda — 2025-08-07 · S · 10,000 shares
- Peetz Christopher — 2025-08-07 · S · 40,000 shares
- Peetz Christopher — 2025-08-11 · S · 40,000 shares
Adoption dates in Mirum Pharmaceuticals, Inc. 7
- 2024-11-22 — stated in 3 filings
- 2024-12-16 — stated in 4 filings
- 2025-08-22 — stated in 2 filings
- 2025-09-18 — stated in 8 filings
- 2026-03-02 — stated in 4 filings
- 2026-03-09 — stated in 3 filings
- 2026-03-18 — stated in 4 filings
Results prints in Mirum Pharmaceuticals, Inc. 9
- 2025-01-13
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-04
- 2026-01-12
- 2026-02-25
- 2026-05-06
- 2026-08-05
Trades before a print in Mirum Pharmaceuticals, Inc. 1
- 2 days before the 2026-08-05 print — 2026-08-03 · S · Howe Jolanda · 1,840 shares
- 12 days before the 2026-02-25 print — 2026-02-13 · S · Ramasastry Saira · 2,000 shares
- 21 days before the 2026-01-12 print — 2025-12-22 · S · Ramasastry Saira · 5,000 shares
- 21 days before the 2026-05-06 print — 2026-04-15 · S · Ramasastry Saira · 2,000 shares
- 24 days before the 2026-01-12 print — 2025-12-19 · S · GREY MICHAEL G · 50,000 shares
- 25 days before the 2026-01-12 print — 2025-12-18 · S · Ramasastry Saira · 1,000 shares
- 25 days before the 2026-01-12 print — 2025-12-18 · S · Ramasastry Saira · 1,000 shares
- 30 days before the 2026-08-05 print — 2026-07-06 · S · BJERKHOLT ERIC · 3,124 shares
- 30 days before the 2026-08-05 print — 2026-07-06 · S · BJERKHOLT ERIC · 1,048 shares
- 30 days before the 2026-08-05 print — 2026-07-06 · S · BJERKHOLT ERIC · 528 shares
- 30 days before the 2026-08-05 print — 2026-07-06 · S · BJERKHOLT ERIC · 300 shares
- 30 days before the 2026-08-05 print — 2026-07-06 · S · Peetz Christopher · 12,134 shares
Interval to Mirum Pharmaceuticals, Inc.’s next reported results date
How the interval and sources are counted →
- 1within 5 days
- 1within 10 days
- 2shortest, days
- 7no later print
- Howe Jolanda 2026-08-03 · S · 2 days before the 2026-08-05 print · SVP, GLOBAL CONTROLLER
Adoption dates Mirum Pharmaceuticals, Inc. states
- 2024-11-22 in 3 filings
- 2024-12-16 in 4 filings
- 2025-08-22 in 2 filings
- 2025-09-18 in 8 filings
- 2026-03-02 in 4 filings
- 2026-03-09 in 3 filings
- 2026-03-18 in 4 filings
Filing text: “10b5-1 Plan adopted by the reporting person on March 9, 2026”
Reported results dates on file
- 2025-01-13
- 2025-02-26
- 2025-05-07
- 2025-08-06
- 2025-11-04
- 2026-01-12
- 2026-02-25
- 2026-05-06
- 2026-08-05
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.